journal
https://read.qxmd.com/read/38389475/one-year-outcomes-with-a-new-mitral-edge-to-edge-repair-device-is-mitral-teer-about-to-conquer-the-world
#21
JOURNAL ARTICLE
Fabien Praz, Daryoush Samim
No abstract text is available yet for this article.
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38389474/letter-the-rota-cut-randomised-trial-push-the-button-harder
#22
JOURNAL ARTICLE
Laura Novelli, Antonio Colombo, Antonio Mangieri
No abstract text is available yet for this article.
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38389473/evolving-indications-for-transcatheter-mitral-edge-to-edge-repair
#23
REVIEW
Mony Shuvy, Francesco Maisano
Transcatheter mitral edge-to-edge repair (TEER) is an established procedure for managing mitral regurgitation (MR) in high-risk patients. It is effective in treating both primary and secondary MR, as reported in the surgical and interventional literature. Over time, TEER has gained popularity and achieved procedural success in various anatomies. The less invasive nature of TEER, along with its high safety profile and immediate haemodynamic improvement suggest potential benefits in high-risk populations who are not normally included in major trials...
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38389472/final-report-of-the-protembo-c-trial-a-prospective-evaluation-of-a-novel-cerebral-protection-device-during-tavi
#24
JOURNAL ARTICLE
Simone Fezzi, Dariusz Jagielak, Radoslaw Targonski, Tobias Schmidt, Christian Frerker, Adam Ryszard Witkowski, Michael Lauterbach, Juergen Leick, Andrejs Erglis, Inga Narbute, Marek Grygier, Marcin Misterski, Derk Frank, Mohamed Abdel-Wahab, Johannes Wilde, Matti Adam, Fernando Gatto, Robert Zivadinov, Michael Dwyer, Nikos Werner, Darren Mylotte
No abstract text is available yet for this article.
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38389471/outcomes-of-transcatheter-edge-to-edge-repair-for-atrial-functional-mitral-regurgitation
#25
JOURNAL ARTICLE
Tetsu Tanaka, Atsushi Sugiura, Johanna Vogelhuber, Can Öztürk, Lukas Böhm, Nihal Wilde, Sebastian Zimmer, Georg Nickenig, Marcel Weber
BACKGROUND: The prognostic benefits of transcatheter edge-to-edge repair (TEER) remain unclear in patients with atrial functional mitral regurgitation (AFMR). AIMS: We aimed to investigate the clinical outcomes of TEER for patients with AFMR. METHODS: We retrospectively classified functional mitral regurgitation (FMR) patients undergoing TEER into those with AFMR or ventricular FMR (VFMR). A residual MR ≤1+ at discharge was considered optimal mitral regurgitation (MR) reduction, and an elevated mean mitral valve pressure gradient (MPG) was defined as an MPG ≥5 mmHg at discharge...
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38389470/procedural-performance-and-healing-response-of-a-novel-lowprofile-transseptal-transcatheter-mitral-valve-replacement-system
#26
JOURNAL ARTICLE
Lauren S Ranard, Yanping Cheng, Genghua Yi, Diane Ordanes, Mitchell McBride, John Butziger, Sean Forde, Giovanni Righini, Paolo Denti, Torsten Vahl
No abstract text is available yet for this article.
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38389469/safety-and-efficacy-of-the-dragonfly-system-for-transcatheter-valve-repair-of-degenerative-mitral-regurgitation-one-year-results-of-the-dragonfly-dmr-trial
#27
MULTICENTER STUDY
Jian'an Wang, Xianbao Liu, Zhaoxia Pu, Mao Chen, Zhenfei Fang, Jun Jin, Jianzhen Dong, Yansong Guo, Biao Cheng, Jiancheng Xiu, Jianfang Luo, Yida Tang, Yan Wang, Xiaomen Chen, Gejun Zhang, Yibing Shao, Guangyuan Song, Lang Hong, Hong Jiang, Yangqin Wu, Yiqiang Yuan, Lianglong Chen, Ben He, Jingfeng Wang, Kai Xu, Yining Yang, Daxin Zhou, Qi Zhang, Yi Li, Kangmu Ma, Yat-Yin Lam, Yaling Han, Junbo Ge, D Scott Lim, For The Dragonflydmr Pivotal Trial Investigators
BACKGROUND: Severe degenerative mitral regurgitation (DMR) can cause a poor prognosis if left untreated. For patients considered at prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) has become an accepted alternative therapy. The DragonFly transcatheter valve repair system is an innovative evolution of the mitral TEER device family to treat DMR. AIMS: Herein we report on the DRAGONFLY-DMR trial (ClinicalTrials.gov: NCT04734756), which was a prospective, single-arm, multicentre study on the safety and effectiveness of the DragonFly system...
February 19, 2024: EuroIntervention
https://read.qxmd.com/read/38343373/chronic-total-occlusion-percutaneous-coronary-intervention-the-next-chapter
#28
JOURNAL ARTICLE
Emmanouil S Brilakis, Ahmed Al-Ogaili
No abstract text is available yet for this article.
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38343372/evaluation-and-management-of-patients-with-coronary-chronic-total-occlusions-considered-for-revascularisation-a-clinical-consensus-statement-of-the-european-association-of-percutaneous-cardiovascular-interventions-eapci-of-the-esc-the-european-association-of
#29
JOURNAL ARTICLE
Alfredo R Galassi, Giuseppe Vadalà, Gerald S Werner, Bernard Cosyns, Georgios Sianos, Jonathan Hill, Dariusz Dudek, Eugenio Picano, Giuseppina Novo, Daniele Andreini, Bernhard L M Gerber, Ronny Buechel, Kambis Mashayekhi, Mathias Thielmann, Margaret B McEntegart, Beatriz Vaquerizo, Carlo Di Mario, Sinisa Stojkovic, Sigrid Sandner, Nikolaos Bonaros, Thomas F Lüscher
Chronic total occlusions (CTOs) of coronary arteries can be found in the context of chronic or acute coronary syndromes; sometimes they are an incidental finding in those apparently healthy individuals undergoing imaging for preoperative risk assessment. Recently, the invasive management of CTOs has made impressive progress due to sophisticated preinterventional assessment, including advanced non-invasive imaging, the availability of novel and dedicated tools for CTO percutaneous coronary intervention (PCI), and experienced interventionalists working in specialised centres...
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38343371/contemporary-outcomes-of-chronic-total-occlusion-percutaneous-coronary-intervention-in-europe-the-ercto-registry
#30
JOURNAL ARTICLE
Giuseppe Vadalà, Alfredo R Galassi, Gerald S Werner, George Sianos, Nicolaus Boudou, Roberto Garbo, Laura Maniscalco, Alexander Bufe, Alexander Avran, Gabriele L Gasparini, Eugenio La Scala, Andrew Ladwiniec, Meruzhan Saghatelyan, Omer Goktekin, Sevket Gorgulu, Nicolaus Reifart, Pierfrancesco Agostoni, Sudhir Rathore, Mohamed Ayoub, Michael Behnes, Iskander Atmowihardjo, Mario Iannaccone, Roberto Diletti, Carlo Di Mario, Kambis Mashayekhi, On Behalf Of The Euro Cto Investigators
BACKGROUND: Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) have reached high procedural success rates thanks to dedicated equipment, evolving techniques, and worldwide adoption of state-of-the-art crossing algorithms. AIMS: We report the contemporary results of CTO PCIs performed by a large European community of experienced interventionalists. Furthermore, we investigated the impact of different risk factors for procedural major adverse cardiac and cerebrovascular events (MACCE) and trends of employment of specific devices like dual lumen microcatheters, guiding catheter extensions, intravascular ultrasound and calcium-modifying tools...
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38343370/dynamic-coronary-roadmap-versus-standard-angiography-for-percutaneous-coronary-intervention-the-randomised-multicentre-dcr4contrast-trial
#31
JOURNAL ARTICLE
Breda Hennessey, Haim Danenberg, Frédéric De Vroey, Ajay J Kirtane, Manish Parikh, Dimitrios Karmpaliotis, John C Messenger, Aaron Strobel, Alejandro Curcio, Martijn S van Mourik, Peter Eshuis, Javier Escaned
BACKGROUND: Decreasing the amount of iodinated contrast is an important safety aspect of percutaneous coronary interventions (PCI), particularly in patients with a high risk of contrast-induced acute kidney injury (CI-AKI). Dynamic Coronary Roadmap (DCR) is a PCI navigation support tool projecting a motion-compensated virtual coronary roadmap overlay on fluoroscopy, potentially limiting the need for contrast during PCI. AIMS: This study investigates the contrast-sparing potential of DCR in PCI, compared to standard angiographic guidance...
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38343369/ostial-right-coronary-artery-lesion-morphology-and-outcomes-after-treatment-with-drug-eluting-stents
#32
JOURNAL ARTICLE
Kei Yamamoto, Takao Sato, Hanan Salem, Yu-Wei Chen, Mitsuaki Matsumura, Nikolas Bletnitsky, Khady N Fall, Megha Prasad, Vivian G Ng, Sanjum S Sethi, Tamim M Nazif, Sahil A Parikh, Torsten P Vahl, Ziad A Ali, Dimitri Karmpaliotis, LeRoy E Rabbani, Michael B Collins, Martin B Leon, Margaret B McEntegart, Jeffery W Moses, Ajay J Kirtane, Gary S Mintz, Akiko Maehara
BACKGROUND: Outcomes after percutaneous coronary intervention (PCI) for de novo ostial right coronary artery (RCA) lesions are poor. AIMS: We used intravascular ultrasound (IVUS) to clarify the morphological patterns of de novo ostial RCA lesions and their associated clinical outcome. METHODS: Among 5,102 RCA IVUS studies, 170 de novo ostial RCA stenoses (within 3 mm from the aorto-ostium) were identified. These were classified as 1) isolated ostial lesions (no disease extending beyond 10 mm from the ostium and without a calcified nodule [CN]); 2) ostial CN, typically with diffuse disease (disease extending beyond 10 mm); and 3) ostial lesions with diffuse disease but without a CN...
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38343368/complete-revascularisation-should-be-immediate-in-stemi-pros-and-cons
#33
JOURNAL ARTICLE
Adnan Kastrati, Thorsten Kessler, Riccardo Rinaldi, Salvatore Brugaletta
No abstract text is available yet for this article.
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38214677/a-double-blind-randomised-placebo-controlled-trial-of-the-coronary-sinus-reducer-in-refractory-angina-design-and-rationale-of-the-orbita-cosmic-trial
#34
RANDOMIZED CONTROLLED TRIAL
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, Florentina Simader, Rachel H Pathimagaraj, Sukhjinder Nijjer, Sayan Sen, Ricardo Petraco, Gerald Clesham, Thomas Johnson, Frank E Harrell, Peter Kellman, Darrel Francis, Matthew Shun-Shin, James Howard, Graham D Cole, Rasha Al-Lamee
The coronary sinus Reducer (CSR) is an hourglass-shaped device which creates an artificial stenosis in the coronary sinus. Whilst placebo-controlled data show an improvement in angina, these results are unreplicated and are the subject of further confirmatory research. The mechanism of action of this unintuitive therapy is unknown. The Coronary Sinus Reducer Objective Impact on Symptoms, MRI Ischaemia, and Microvascular Resistance (ORBITA-COSMIC) trial is a randomised, placebo-controlled, double-blind trial investigating the efficacy of the CSR...
February 5, 2024: EuroIntervention
https://read.qxmd.com/read/38224258/what-should-we-expect-when-we-explant
#35
JOURNAL ARTICLE
Uri Landes, Emanuel Harari
No abstract text is available yet for this article.
January 15, 2024: EuroIntervention
https://read.qxmd.com/read/38224257/aortic-stenosis-management-current-evolution-and-future-challenges
#36
JOURNAL ARTICLE
Andrea Scotti, Azeem Latib
No abstract text is available yet for this article.
January 15, 2024: EuroIntervention
https://read.qxmd.com/read/38224256/high-risk-pci-one-device-cannot-fix-it-all
#37
JOURNAL ARTICLE
Alaide Chieffo, Mario Iannaccone
No abstract text is available yet for this article.
January 15, 2024: EuroIntervention
https://read.qxmd.com/read/38224255/impact-of-transcatheter-heart-valve-type-on-outcomes-of-surgical-explantation-after-failed-transcatheter-aortic-valve-replacement-the-explant-tavr-international-registry
#38
JOURNAL ARTICLE
Syed Zaid, Neal S Kleiman, Sachin S Goel, Molly I Szerlip, Michael J Mack, Mateo Marin-Cuartas, Siamak Mohammadi, Tamim M Nazif, Axel Unbehaun, Martin Andreas, Derek R Brinster, Newell B Robinson, Lin Wang, Basel Ramlawi, Lenard Conradi, Nimesh D Desai, John K Forrest, Rodrigo Bagur, Tom C Nguyen, Ron Waksman, Lionel Leroux, Eric Van Belle, Kendra J Grubb, Hasan A Ahmad, Paolo Denti, Thomas Modine, Vinayak N Bapat, Tsuyoshi Kaneko, Michael J Reardon, Gilbert H L Tang, On Behalf Of The Explant-Tavr Registry Investigators
BACKGROUND: There are limited data on the impact of transcatheter heart valve (THV) type on the outcomes of surgical explantation after THV failure. AIMS: We sought to determine the outcomes of transcatheter aortic valve replacement (TAVR) explantation for failed balloon-expandable valves (BEV) versus self-expanding valves (SEV). METHODS: From November 2009 to February 2022, 401 patients across 42 centres in the EXPLANT-TAVR registry underwent TAVR explantation during a separate admission from the initial TAVR...
January 15, 2024: EuroIntervention
https://read.qxmd.com/read/38224254/clinical-characteristics-and-outcomes-of-patients-requiring-prolonged-mechanical-circulatory-support-after-high-risk-percutaneous-coronary-intervention
#39
JOURNAL ARTICLE
Sugi Min, Mir Babar Basir, Alejandro Lemor, Zhipeng Zhou, Arsalan Abu-Much, Björn Redfors, Julia B Thompson, Alexander G Truesdell, Aditya S Bharadwaj, Yanru Li, Amir Kaki, Brigitta C Brott, David H Wohns, Perwaiz M Meraj, Ramesh Daggubati, Cindy L Grines, William W O'Neill, Jeffrey W Moses
BACKGROUND: There are limited data on the clinical characteristics and outcomes of patients who require prolonged mechanical circulatory support (MCS) after Impella-supported high-risk percutaneous coronary intervention (HR-PCI). AIMS: The aim of this study is to describe the contemporary clinical characteristics, outcomes, and predictors associated with prolonged MCS support after assisted HR-PCI. METHODS: Patients enrolled in the prospective, multicentre, clinical endpoint-adjudicated PROTECT III study who had undergone HR-PCI using Impella were evaluated...
January 15, 2024: EuroIntervention
https://read.qxmd.com/read/38224253/contemporary-guideline-directed-management-of-patients-with-severe-aortic-valve-stenosis
#40
JOURNAL ARTICLE
Xi Wang, Ketina Arslani, Philippe Nuyens, Nicholas J Montarello, Maarten Vanhaverbeke, Gintautas Bieliauskas, Lars Sondergaard, Ole De Backer
BACKGROUND: Both surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are Class Ia recommended therapies for specific subgroups of severe aortic stenosis (AS) patients in the latest 2021 European guidelines. AIMS: We aimed to report on the multidisciplinary Heart Team evaluation process and real-world practice of treating severe symptomatic AS in East Denmark in the context of the latest European guideline recommendations. METHODS: All consecutive patients with severe AS referred for intervention in 2021 (N=672) were discussed in a multidisciplinary Heart Team meeting...
January 15, 2024: EuroIntervention
journal
journal
41103
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.